Type-2 diabetes has been linked to pancreatic cancer. There have been years of speculation about whether diabetes affects pancreatic cancer patients or, is it an early sign of cancer?
Researchers at the University of Basel looked at the use of anti-diabetic drugs and the risk of pancreatic cancer in a study reported in the American Journal of Gastroenterology published in January 2012.
Sometimes when we take diabetes medicine for a long time it will cause some side effects like a genital infection. Many people suffer from this health problem. This infection can worsen quickly and require multiple surgeries and result in disfigurement and death.
Image Source: Google
Persons and family members of persons who are suffered from genital infection are eligible for free, no-obligation case reviews with an attorney handling national diabetes drug infection lawsuit claims. You can search for diabetes drug infection legal advisor to file a case against companies.
Study 1: A total of 2,763 participants with pancreatic cancer were included in this study. The use of metformin is associated with a reduced risk of pancreatic cancer in women. Insulin is associated with an increased risk of pancreatic cancer.
Study 2: A study reported in Diabetes Care, February 2012, showed similar results, comparing the survival rates of British cancer patients using and not using metformin. A total of 8,392 people diagnosed with type 2 diabetes were included in this study. Diabetics who use metformin show a better survival rate than those who use sulfonylurea or insulin.
The above study is consistent with the study reported in the journal Metabolism in October 2011. Six percent of participants were diagnosed with cancer during that time. Those who use insulin have an increased risk of being diagnosed with cancer while those using metformin have a lower risk of a cancer diagnosis.